Beta Bionics BBNX
$13.36 +$0.04 (+0.30%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.36 0.00%
Open$13.05
Prev close$13.32
Day range$12.92 – $13.85
Volume960.3K
Market cap$726.34M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$35.51M+30.3% YoY
Operating profit-$26.61M-56.1% YoY
Net profit-$24.35M-71.4% YoY
Diluted EPS-$0.52-57.6% YoY
Free cash flow-$14.56M-45.5% YoY
Operating cash flow-$12.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin58.6%
Operating margin-72.7%
Net margin-65.3%
Return on equity-23.9%
Return on assets-21.5%
Return on invested capital-26.1%
Current ratio8.92
Liabilities / assets9.5%
Cash & investments$240.20M
Total debt$4.65M
Net cash (debt)$235.56M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $35.51M | $32.01M | $27.63M | $100.25M | $32.12M |
| Total Operating Revenue | $35.51M | $32.01M | $27.63M | $100.25M | $32.12M |
| Cost of Revenue | $15.17M | $13.11M | $11.19M | $44.71M | $13.18M |
| Gross Profit | $20.33M | $18.90M | $16.44M | $55.54M | $18.94M |
| Operating Expense | $46.94M | $44.48M | $40.71M | $127.22M | $35.07M |
| Selling and Admin Expenses | $34.97M | $34.24M | $30.35M | $92.43M | $24.94M |
| -Selling & Marketing Expense | $25.12M | $24.64M | $20.74M | $61.40M | $16.33M |
| -General & Admin Expense | $9.84M | $9.60M | $9.62M | $31.03M | $8.60M |
| Research & Development | $11.98M | $10.24M | $10.36M | $34.79M | $10.13M |
| Operating Profit | -$26.61M | -$25.58M | -$24.27M | -$71.68M | -$16.12M |
| Net Non-Operating Interest Income (Expense) | $2.26M | $2.18M | $2.38M | $10.93M | $2.66M |
| Non-Operating Interest Income | $2.26M | $2.18M | $2.38M | $10.93M | $2.66M |
| Other Income (Expense) | -$2,000.00 | -$2,000.00 | – | -$12.45M | $0.00 |
| Other Non-Operating Income (Expenses) | -$2,000.00 | -$2,000.00 | – | -$1,000.00 | $0.00 |
| Pretax Profit | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Net Profit | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Profit from Continuing Operations | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Net Income to Parent Company | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Net Income to Common Stockholders | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Basic EPS | -$0.52 | -$0.53 | -$0.49 | -$1.81 | -$0.30 |
| Diluted EPS | -$0.52 | -$0.53 | -$0.49 | -$1.81 | -$0.30 |
| Gain on Sale of Security | – | – | – | -$12.45M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $443.76M | $292.39M | $304.42M | $328.74M | $328.74M |
| Total Current Assets | $292.95M | $231.03M | $247.99M | $267.91M | $267.91M |
| Cash and Cash Equivalents & Short-Term Investments | $240.20M | $180.49M | $199.52M | $219.13M | $219.13M |
| -Cash and Cash Equivalents | $81.55M | $44.32M | $30.21M | $31.58M | $31.58M |
| -Short Term Investments | $158.65M | $136.17M | $169.31M | $187.55M | $187.55M |
| Receivables | $23.75M | $20.25M | $18.14M | $19.89M | $19.89M |
| -Accounts Receivable | $20.67M | $18.05M | $15.75M | $17.12M | $17.12M |
| -Accrued Interest Receivable | $2.79M | $1.91M | $2.14M | $2.51M | $2.51M |
| -Taxes Receivable | $293,000.00 | $293,000.00 | $251,000.00 | $265,000.00 | $265,000.00 |
| Prepaid Assets | $5.92M | $6.28M | $6.50M | $7.06M | $7.06M |
| Inventory | $22.97M | $23.92M | $23.73M | $21.72M | $21.72M |
| Restricted Cash | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 | $100,000.00 |
| Total Non-Current Assets | $150.81M | $61.35M | $56.43M | $60.84M | $60.84M |
| Net PPE | $17.17M | $16.56M | $16.39M | $15.23M | $15.23M |
| -Gross PPE | $25.10M | $23.61M | $22.73M | $20.98M | $20.98M |
| -Accumulated Depreciation | -$7.94M | -$7.05M | -$6.34M | -$5.76M | -$5.76M |
| Investments and Advances | $133.44M | $44.65M | $39.87M | $45.43M | $45.43M |
| -Available for Sale Securities | $133.44M | $44.65M | $39.87M | $45.43M | $45.43M |
| Other Non-Current Assets | $212,000.00 | $141,000.00 | $181,000.00 | $180,000.00 | $180,000.00 |
| Total Liabilities | $42.38M | $36.02M | $33.17M | $41.13M | $41.13M |
| Total Current Liabilities | $32.84M | $26.02M | $23.19M | $30.92M | $30.92M |
| Payables | $4.68M | $5.35M | $2.32M | $5.00M | $5.00M |
| -Accounts Payable | $4.68M | $5.35M | $2.32M | $5.00M | $5.00M |
| Current Accrued Expenses | $7.98M | $5.03M | $6.11M | $7.84M | $7.84M |
| Short-Term Debt and Capital Lease Obligation | $1.45M | $1.59M | $1.84M | $1.94M | $1.94M |
| -Current Capital Lease Obligation | $1.45M | $1.59M | $1.84M | $1.94M | $1.94M |
| Current Provisions | $1.76M | $1.66M | $1.61M | $1.61M | $1.61M |
| Current Deferred Liabilities | $2.05M | $1.88M | $1.71M | $1.56M | $1.56M |
| Other Current Liabilities | $1.27M | $554,000.00 | $623,000.00 | $328,000.00 | $328,000.00 |
| Total Non-Current Liabilities | $9.54M | $10.00M | $9.98M | $10.21M | $10.21M |
| Long Term Debt and Capital Lease Obligation | $4.65M | $4.92M | $5.07M | $5.37M | $5.37M |
| -Long Term Capital Lease Obligation | $4.65M | $4.92M | $5.07M | $5.37M | $5.37M |
| Non-Current Deferred Liabilities | $3.48M | $3.45M | $3.35M | $3.30M | $3.30M |
| Other Non-Current Liabilities | $1.41M | $1.63M | $1.56M | $1.55M | $1.55M |
| Total Equity | $401.38M | $256.37M | $271.25M | $287.61M | $287.61M |
| Stockholders' Equity | $401.38M | $256.37M | $271.25M | $287.61M | $287.61M |
| Capital Stock | $5,000.00 | $5,000.00 | $5,000.00 | $4,000.00 | $4,000.00 |
| -Common Stock | $5,000.00 | $5,000.00 | $5,000.00 | $4,000.00 | $4,000.00 |
| Additional Paid-In Capital | $841.84M | $671.99M | $663.17M | $657.14M | $657.14M |
| Retained Earnings | -$439.59M | -$415.24M | -$391.83M | -$369.94M | -$369.94M |
| Gains/Losses Not Affecting Retained Earnings | -$877,000.00 | -$390,000.00 | -$96,000.00 | $403,000.00 | $403,000.00 |
| Convertible preferred securities | – | $0.00 | – | $0.00 | $0.00 |
| Non-Current Deferred Assets | – | – | – | $0.00 | $0.00 |
| Derivative Product Liabilities | – | – | – | $0.00 | $0.00 |
| -Preferred Stock | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$12.29M | -$14.62M | -$23.83M | -$50.93M | -$8.63M |
| Net cash flow from continuing operations | -$12.29M | -$14.62M | -$23.83M | -$50.93M | -$8.63M |
| Net Income from Continuing Operations | -$24.35M | -$23.40M | -$21.90M | -$73.20M | -$13.47M |
| Depreciation & Depletion & Amortization | $1.31M | $1.12M | $987,000.00 | $2.88M | $935,000.00 |
| Change in Working Capital | $4.26M | $513,000.00 | -$8.21M | -$8.99M | -$1.34M |
| -Change in Receivables | -$2.65M | -$2.32M | $1.37M | -$5.16M | -$5.60M |
| -Change in Inventory | $1.34M | -$214,000.00 | -$1.80M | -$9.88M | -$2.20M |
| -Change in Prepaid Assets | -$530,000.00 | $415,000.00 | $951,000.00 | -$5.81M | -$413,000.00 |
| -Change in Payables and Accrued Expense | $6.62M | $2.64M | -$8.55M | $9.52M | $6.39M |
| -Change in Other Current Assets | -$71,000.00 | $40,000.00 | -$1,000.00 | -$30,000.00 | $3,000.00 |
| -Change in Other Current Liabilities | -$629,000.00 | -$329,000.00 | -$380,000.00 | $311,000.00 | -$42,000.00 |
| -Change In Other Working Capital | $191,000.00 | $280,000.00 | $201,000.00 | $2.06M | $526,000.00 |
| Net cash flow from investing | -$114.08M | $26.93M | $21.84M | -$162.81M | $658,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$114.08M | $26.93M | $21.84M | -$162.81M | $658,000.00 |
| Net PPE Purchase and Sale | -$2.28M | -$1.04M | -$1.38M | -$5.30M | -$1.90M |
| Net Investment Purchase and Sale | -$111.81M | $27.97M | $23.22M | -$157.51M | $2.56M |
| Financing Cash Flow | $163.60M | $1.80M | $623,000.00 | $214.87M | $1.06M |
| Net Cash Flow from Continuing Financing Activities | $163.60M | $1.80M | $623,000.00 | $214.87M | $1.06M |
| Net Common Stock Issuance | $161.80M | $0.00 | $0.00 | $210.12M | -$904,000.00 |
| Proceeds from Stock Option Exercised | $1.80M | $1.80M | $623,000.00 | $4.76M | $1.96M |
| Ending Cash Balance | $81.65M | $44.42M | $30.31M | $31.68M | $31.68M |
| Net Change in Cash | $37.23M | $14.11M | -$1.37M | $1.14M | -$6.91M |
| Beginning Cash Balance | $44.42M | $30.31M | $31.68M | $30.53M | $38.59M |
| Free Cash Flow | -$14.56M | -$15.66M | -$25.21M | -$56.22M | -$10.53M |
| Other Non-Cash Items | – | – | $86,000.00 | -$2.05M | -$25,000.00 |
| Gain/Loss from Continuing Operations | – | – | – | $12.48M | $31,000.00 |
| Net Preferred Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on BBNX.
Sign in to join the discussion.